A new regulation and registry covering investigational medicinal products mandates reporting and supports multinational trials.

Pharma companies are more compliant in posting results compared to universities.

The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

Less than half of completed stem cell studies in humans are published in peer-reviewed journals, according to an analysis of regenerative medicine trials. 

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.